Glutamine stress promotes metastatic potential via hexosamine biosynthetic pathway activity in KRAS/STK11-mutant lung adenocarcinoma

Lung cancer remains the most deadly form of the disease, claiming more lives than any other. Among the many variations of this illness, a specific type driven by a mutation in a gene called KRAS is particularly aggressive. When this mutation occurs alongside a second genetic change—the loss of a protective gene named STK11—the cancer becomes even more dangerous, spreading quickly to other parts of the body and resisting standard treatments. For years, scientists have noticed that these specific cancer cells seem to have a voracious appetite for a nutrient called glutamine. Because the cells rely so heavily on this substance to survive, researchers have long hoped that simply starving the tumor of glutamine would be an effective way to kill it. The logic seemed sound: if the cancer needs glutamine to live, cutting off the supply should cause it to collapse.

However, the story of how cancer cells survive is rarely simple. In a new study, researchers at the University of Vermont have uncovered a surprising twist in this narrative. They found that when these specific lung cancer cells are deprived of glutamine, they do not simply wither away. Instead, they undergo a rapid and clever metabolic shift that allows them to not only survive the starvation but to become more dangerous. By rerouting the little bit of internal glutamine they have left, the cells activate a protective pathway that helps them detach from their original location, resist death, and invade new tissues. This discovery suggests that trying to starve these tumors of glutamine might inadvertently trigger the very behaviors that make them so deadly, turning a potential treatment into a catalyst for metastasis.

The researchers began their investigation by looking at how these cancer cells use energy. They studied two different types of lung cancer cells, both carrying the dangerous KRAS mutation, but with one set having the protective STK11 gene and the other set lacking it. When they measured the energy production of these cells, they found that the ones missing the STK11 gene were already working at maximum capacity, burning through glutamine at a high rate to fuel their growth. This confirmed the idea that these cells are addicted to the nutrient. But the real surprise came when the scientists removed glutamine from the cells' environment.

In a healthy cell, or in a cancer cell that still has the STK11 gene, removing glutamine causes energy production to drop sharply. The cell struggles to keep going. But in the cells missing STK11, something different happened. Instead of shutting down, these cells quickly reorganized their internal machinery. They stopped trying to burn glutamine for energy in the usual way and instead diverted their remaining resources into a different chemical pathway known as the hexosamine biosynthetic pathway. Think of this pathway as a specialized factory line inside the cell that builds sugar-coated molecules. While this factory usually runs at a low level, the stress of starvation caused the cancer cells to ramp it up significantly.

This shift was not just a random reaction; it was a strategic move that changed the behavior of the cancer cells. The researchers observed that when the STK11-missing cells were starved of glutamine, they began to produce high levels of specific sugar molecules that coat the surface of the cell. These sugar coats act like a shield and a tool. In the lab, the researchers saw that the starved, STK11-missing cells started to let go of the surface they were growing on. Normally, when a cell loses its grip on the ground, it dies. This process, called anoikis, is a natural safety mechanism that prevents cells from wandering where they do not belong. However, the starved cancer cells resisted this death. They floated freely, alive and ready to move.

To test if this sugar-coating factory was the cause of this dangerous behavior, the scientists used a drug designed to block the pathway. When they blocked the factory, the cells lost their ability to survive detachment. They could no longer resist death when they let go of their surface, and they could not reattach and grow in a new location. This proved that the activation of this pathway was the direct reason the cells were becoming so resilient. The researchers then took this a step further by growing the cells into tiny, three-dimensional balls that mimic a tumor. When these balls were placed in a nutrient-poor environment, the STK11-missing cells did not just sit there; they broke apart and sent individual cells out to invade the surrounding material. This is a hallmark of metastasis, the process by which cancer spreads. When the sugar-coating pathway was blocked, this invasion stopped.

The study highlights a critical lesson about how cancer adapts. The researchers found that the cells did not just passively suffer from a lack of glutamine; they actively rewired their metabolism to survive it. This adaptation involved a trade-off. The cells gave up some of their energy production to fuel the sugar-coating pathway, which in turn allowed them to detach, survive, and spread. The researchers noted that this change happened very quickly, within just a few hours of starvation, suggesting that the cells are primed to switch strategies the moment resources become scarce.

This finding challenges the idea that starving these tumors of glutamine is a straightforward solution. The study suggests that for patients with this specific genetic profile, simply cutting off glutamine might select for the most aggressive cells—the ones that can switch to this survival mode and become more metastatic. The researchers propose that the sugar-coating pathway acts as a protective shunt, a safety valve that allows the cancer to endure the stress of starvation. By understanding this mechanism, scientists can see that the tumor's response to stress is not a sign of weakness, but a sophisticated adaptation that drives the disease forward.

The work does not offer an immediate new cure, but it fundamentally changes how scientists view the relationship between diet, metabolism, and cancer spread. It shows that the tumor microenvironment, which is often low in nutrients, can act as a trigger for the cancer to become more invasive. The researchers emphasize that future treatments for this type of lung cancer may need to target not just the cancer's hunger for glutamine, but also the specific metabolic pathways it uses to survive that hunger. If doctors can block both the fuel supply and the survival mechanism, they might be able to stop the cancer from adapting and spreading. For now, the study stands as a clear warning that in the complex world of cancer biology, trying to starve a tumor can sometimes feed its most dangerous traits.